Talphera (TLPH) Shares Outstanding (Diluted Average) (2021 - 2023)
Talphera (TLPH) recorded quarterly Shares Outstanding (Diluted Average) of $14.3 million in Q4 2023, down 14.89% quarter-over-quarter from $16.8 million in Q3 2023, and up 92.57% on a YoY basis from $7.4 million in Q4 2022.
Talphera (TLPH) Shares Outstanding (Diluted Average) (2021 - 2023) Analysis & Trends
Talphera's Shares Outstanding (Diluted Average) history runs 3 years deep, the most recent figure standing at $14.3 million for Q4 2023.
- In Q4 2023, Shares Outstanding (Diluted Average) rose 92.57% year-over-year to $14.3 million; the TTM figure through Dec 2023 stood at $14.3 million (up 92.57% YoY), while the FY2023 annual figure was $14.3 million, up 92.57% from the prior year.
- Shares Outstanding (Diluted Average) was $14.3 million for Q4 2023 at Talphera, down from $16.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $119.1 million in Q2 2021 to a low of $5.9 million in Q3 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $19.4 million across 3 years, with a median of $7.4 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) plunged 93.82% in 2022, then jumped 127.16% in 2023.
- A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $6.0 million in 2021, then advanced by 23.59% to $7.4 million in 2022, then jumped by 92.57% to $14.3 million in 2023.
- The last three Shares Outstanding (Diluted Average) figures came in at $14.3 million (Q4 2023), $16.8 million (Q3 2023), and $10.9 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 14.26 Mn |
| Sep 30, 2023 | 16.76 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 7.41 Mn |
| Sep 30, 2022 | 7.38 Mn |
| Jun 30, 2022 | 7.36 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 5.99 Mn |
| Sep 30, 2021 | 5.86 Mn |
| Jun 30, 2021 | 119.12 Mn |